Biodexa Pharmaceuticals (BDRX) Return on Assets (2016 - 2025)
Biodexa Pharmaceuticals (BDRX) reported Return on Assets of 0.0% for Q4 2025, up 1.0% on a YoY basis from 0.0% in Q4 2024, and up 54.61% sequentially from 0.01% in Q2 2025.
Biodexa Pharmaceuticals (BDRX) Return on Assets (2016 - 2025) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 10 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.
- For the quarter ending Q4 2025, Return on Assets rose 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (up 1.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Assets grew to 0.0% in Q4 2025, from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.04% in Q2 2021.
- A 5-year average of 0.02% and a median of 0.01% in 2024 frame the typical range for Return on Assets.
- Across the five-year window, Return on Assets fell 4 bps in 2021 and advanced 4 bps in 2022, its largest moves.
- Tracing BDRX's Return on Assets over 5 years: stood at 0.04% in 2021, then jumped by 79 bps to 0.01% in 2022, then tumbled by 176 bps to 0.03% in 2023, then soared by 60 bps to 0.01% in 2024, then jumped by 56 bps to 0.0% in 2025.
- Business Quant data shows BDRX's Return on Assets at 0.0% in Q4 2025, 0.01% in Q2 2025, and 0.01% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -0.01% |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | -0.80% |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | 0.00% |
| 10 | Biodexa Pharmaceuticals | 17.77 Bn | 17.76 Bn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Jun 30, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Dec 31, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Jun 30, 2022 | -0.01% |
| Jun 30, 2021 | -0.04% |
| Jun 30, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Dec 31, 2017 | 0.00% |
| Jun 30, 2017 | -0.01% |
| Dec 31, 2016 | -0.01% |
| Jun 30, 2016 | -0.01% |